Arginine vasopressin deficiency and conivaptan (a V1a–V2 receptor antagonist) treatment reverses liver damage and fibrosis in rats with chronic portocaval anastomosis

International Journal of Experimental Pathology · Published 2023-03-25 · DOI 10.1111/iep.12476

Authors being retrieved — see the publisher record. https://doi.org/10.1111/iep.12476

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year
2023

Related articles